Answers are grounded in this paper and cite their sources.
Patients with TRD exhibit a significantly higher demand on healthcare resources and higher overall payments compared to Non-TRD patients. The findings suggest that there are current challenges in adequately managing this difficult-to-treat patient group and there remains a high unmet need for new therapies.
No takes yet. Share an insight, caveat, or question.
McIntyre et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: